Related Experiment Video

Updated: Jun 1, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

Rheumatoid arthritis and metabolic syndrome

Viviane Roseli da Cunha1, Claiton Viegas Brenol, João Carlos Tavares Brenol

  • 1Universidade Federal do Rio Grande do Sul – UFRGS, Brazil.

Revista Brasileira De Reumatologia
|June 1, 2011
PubMed

Insights

Patients with rheumatoid arthritis (RA) face reduced life expectancy and higher cardiovascular disease (CVD) risk. Metabolic syndrome (MetS) significantly worsens this risk, highlighting the need for further investigation into RA

Area of Science:

  • Rheumatology
  • Cardiology
  • Metabolic Diseases

Background:

  • Rheumatoid arthritis (RA) is linked to a 3-10 year reduction in life expectancy.
  • Cardiovascular disease (CVD) is the primary cause of mortality in RA patients, with acute myocardial infarction occurring up to four times more frequently.
  • Systemic inflammation in RA, combined with metabolic syndrome (MetS), elevates CVD and coronary atherosclerosis risk.

Purpose of the Study:

  • To review the prevalence of MetS in RA patients.
  • To identify factors contributing to atherosclerosis development in RA.
  • To assess clinical RA aspects and their association with MetS development.

Main Methods:

  • Literature review on MetS prevalence in RA.
  • Analysis of factors implicated in atherosclerosis in RA patients.
  • Evaluation of clinical RA characteristics and their link to MetS.

Main Results:

  • RA patients exhibit an increased prevalence of MetS.
  • The interplay between RA disease characteristics (duration, activity, glucocorticoid treatment) and MetS requires further definition.
  • MetS and RA's inflammatory state synergistically increase CVD risk.

Conclusions:

  • MetS is a significant comorbidity in RA, exacerbating cardiovascular risk.
  • Understanding the relationship between RA clinical features and MetS is crucial for risk stratification.
  • Targeting MetS in RA management may mitigate cardiovascular complications.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...